Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Hemophilia Alliance is a non-profit organization that supports federally funded Hemophilia Treatment Centers (HTCs) across the United States. It provides advocacy, legal, and operational resources to ensure that HTCs can provide high-quality care to individuals with bleeding disorders. A core component of its business is acting as a Group Purchasing Organization (GPO), negotiating favorable pricing for factor replacement therapies and other medications for its member centers. The organization also funds research and community grants to improve the lives of patients with hemophilia and related conditions. It plays a critical role in helping HTCs navigate the complexities of the 340B Drug Pricing Program to ensure the sustainability of the comprehensive care model.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Hemophilia Alliance.